Free Trial
→ Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th... (From Banyan Hill Publishing) (Ad)tc pixel Free ALAB Stock Alerts

Astera Labs (ALAB) Financials

Astera Labs logo
$306.88 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$305.75 -1.13 (-0.37%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Astera Labs

Annual Income Statements for Astera Labs

This table shows Astera Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -58 -26 -83 219
Consolidated Net Income / (Loss)		 -58 -26 -83 219
Net Income / (Loss) Continuing Operations		 -58 -26 -83 219
Total Pre-Tax Income 		-58 -23 -82 218
Total Operating Income		 -60 -29 -116 173
Total Gross Profit		 59 80 303 645
Total Revenue		 80 116 396 853
Operating Revenue		 80 116 396 853
Total Cost of Revenue		 21 36 94 207
Operating Cost of Revenue		 21 36 94 207
Total Operating Expenses		 119 109 419 472
Selling, General & Admin Expense		 21 16 94 88
Marketing Expense		 24 20 124 80
Research & Development Expense		 74 73 201 304
Total Other Income / (Expense), net		 2.61 6.55 34 45
Interest & Investment Income		 2.61 6.55 34 45
Income Tax Expense		 0.76 3.31 1.64 -0.98
Basic Earnings per Share		 ($1.71) ($0.71) ($0.64) $1.32
Weighted Average Basic Shares Outstanding		 34.17M 37.13M 131.26M 166.41M
Diluted Earnings per Share		 ($1.71) ($0.71) ($0.64) $1.22
Weighted Average Diluted Shares Outstanding		 34.17M 37.13M 131.26M 179.55M
Weighted Average Basic & Diluted Shares Outstanding		 - - 162.15M 170.21M

Quarterly Income Statements for Astera Labs

This table shows Astera Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -3.12 14 -93 -7.55 -7.59 25 32 51 91 45 80
Consolidated Net Income / (Loss)		 -3.12 14 -93 -7.55 -7.59 25 32 51 91 45 80
Net Income / (Loss) Continuing Operations		 -3.12 14 -93 -7.55 -7.59 25 32 51 91 45 80
Total Pre-Tax Income 		-0.25 11 -80 -14 2.02 11 22 51 67 79 73
Total Operating Income		 -1.98 9.02 -83 -24 -8.90 0.14 11 40 55 67 62
Total Gross Profit		 28 39 51 60 88 104 119 146 176 204 235
Total Revenue		 37 51 65 77 113 141 159 192 231 271 308
Operating Revenue		 37 51 65 77 113 141 159 192 231 271 308
Total Cost of Revenue		 8.82 11 15 17 25 37 40 46 55 66 73
Operating Cost of Revenue		 8.82 11 15 17 25 37 40 46 55 66 73
Total Operating Expenses		 30 30 133 84 97 104 108 106 120 138 173
Selling, General & Admin Expense		 3.95 5.36 24 22 23 25 22 20 22 24 26
Marketing Expense		 5.51 5.00 56 22 23 23 22 19 19 20 22
Research & Development Expense		 21 20 54 40 51 57 65 67 79 94 126
Total Other Income / (Expense), net		 1.72 1.67 2.55 10 11 11 10 11 11 12 12
Interest & Investment Income		 1.72 1.67 2.55 10 11 11 10 11 11 12 12
Income Tax Expense		 2.87 -3.63 13 -6.54 9.61 -14 -10 -0.56 -24 34 -6.90
Basic Earnings per Share		 ($0.08) $0.41 ($1.77) ($0.05) ($0.05) $1.23 $0.19 $0.31 $0.54 $0.28 $0.47
Weighted Average Basic Shares Outstanding		 37.47M 37.13M 52.53M 155.20M 156.83M 131.26M 163.19M 165.43M 167.44M 166.41M 170.73M
Diluted Earnings per Share		 ($0.08) $0.41 ($1.77) ($0.05) ($0.05) $1.23 $0.18 $0.29 $0.50 $0.25 $0.44
Weighted Average Diluted Shares Outstanding		 37.47M 37.13M 52.53M 155.20M 156.83M 131.26M 178.12M 178.10M 180.63M 179.55M 181.16M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 155.70M 156.66M 158.61M 162.15M 164.92M 166.22M 168.90M 170.21M 171.41M

Annual Cash Flow Statements for Astera Labs

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 25 -31 35 88
Net Cash From Operating Activities		 -36 -13 137 319
Net Cash From Continuing Operating Activities		 -36 -13 137 319
Net Income / (Loss) Continuing Operations		 -58 -26 -83 219
Consolidated Net Income / (Loss)		 -58 -26 -83 219
Depreciation Expense		 0.81 1.78 3.15 6.83
Amortization Expense		 -0.53 -1.66 -8.44 -7.93
Non-Cash Adjustments To Reconcile Net Income		 32 23 239 167
Changes in Operating Assets and Liabilities, net		 -9.97 -9.68 -13 -66
Net Cash From Investing Activities		 -91 -18 -758 -241
Net Cash From Continuing Investing Activities		 -91 -18 -758 -241
Purchase of Property, Plant & Equipment		 -3.87 -2.76 -34 -38
Acquisitions		 - 0.00 0.00 -29
Purchase of Investments		 -89 -126 -931 -858
Sale and/or Maturity of Investments		 2.00 111 209 683
Other Investing Activities, net		 0.00 0.00 -1.41 -0.50
Net Cash From Financing Activities		 152 -0.50 656 9.80
Net Cash From Continuing Financing Activities		 152 -0.50 656 9.80
Repurchase of Common Equity		 -0.31 -1.62 -5.87 0.00
Issuance of Common Equity		 0.00 0.00 676 7.98
Other Financing Activities, net		 2.12 1.12 -15 1.83

Quarterly Cash Flow Statements for Astera Labs

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -56 7.38 651 -275 -295 -46 6.95 76 -22 26 -19
Net Cash From Operating Activities		 -0.33 14 3.65 30 64 40 11 135 78 95 75
Net Cash From Continuing Operating Activities		 -0.33 14 3.65 30 64 40 11 135 78 95 75
Net Income / (Loss) Continuing Operations		 -3.12 14 -93 -7.55 -7.59 25 32 51 91 45 80
Consolidated Net Income / (Loss)		 -3.12 14 -93 -7.55 -7.59 25 32 51 91 45 80
Depreciation Expense		 0.48 0.54 0.61 0.72 0.85 0.97 1.13 1.39 1.47 2.85 3.71
Amortization Expense		 -0.40 -0.59 -0.57 -1.07 -3.23 -3.47 -2.54 -1.95 -1.79 -1.65 -1.20
Non-Cash Adjustments To Reconcile Net Income		 3.81 4.18 99 45 46 49 42 40 43 42 51
Changes in Operating Assets and Liabilities, net		 -1.10 -4.06 -2.23 -7.77 27 -31 -62 45 -56 7.05 -59
Net Cash From Investing Activities		 -56 -5.96 -4.25 -302 -359 -91 -3.94 -64 -101 -73 -94
Net Cash From Continuing Investing Activities		 -56 -5.96 -4.25 -302 -359 -91 -3.94 -64 -101 -73 -94
Purchase of Property, Plant & Equipment		 -0.74 -1.01 -3.42 1.32 -17 -15 -4.54 -2.02 -12 -19 -7.59
Acquisitions		 - - - - - - 0.00 - - - -65
Purchase of Investments		 -76 -23 -23 -322 -379 -206 -191 -214 -260 -193 -157
Sale and/or Maturity of Investments		 20 18 22 19 36 131 191 152 171 168 138
Other Investing Activities, net		 - - - - - - 0.00 - - - -2.50
Net Cash From Financing Activities		 0.64 -1.06 652 -2.34 0.95 5.65 0.39 4.74 0.95 3.73 0.08
Net Cash From Continuing Financing Activities		 0.64 -1.06 652 -2.34 0.95 5.65 0.39 4.74 0.95 3.73 0.08
Other Financing Activities, net		 0.66 0.45 -19 0.70 0.95 2.56 0.39 0.39 0.95 0.10 0.08

Annual Balance Sheets for Astera Labs

This table presents Astera Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 196 1,055 1,532
Total Current Assets		 186 1,013 1,362
Cash & Equivalents		 45 80 168
Short-Term Investments		 104 835 1,021
Accounts Receivable		 8.34 39 83
Inventories, net		 24 43 59
Prepaid Expenses		 4.06 17 31
Plant, Property, & Equipment, net		 4.71 36 92
Total Noncurrent Assets		 5.77 5.88 78
Goodwill		 - - 19
Other Noncurrent Operating Assets		 5.77 5.88 59
Total Liabilities & Shareholders' Equity		 196 1,055 1,532
Total Liabilities		 39 90 168
Total Current Liabilities		 35 87 133
Accounts Payable		 6.34 27 42
Accrued Expenses		 29 60 91
Total Noncurrent Liabilities		 3.79 3.17 35
Other Noncurrent Operating Liabilities		 3.79 3.17 35
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -98 965 1,364
Total Preferred & Common Equity		 -98 965 1,364
Total Common Equity		 -98 965 1,364
Common Stock		 27 1,173 1,349
Retained Earnings		 -125 -209 10
Accumulated Other Comprehensive Income / (Loss)		 0.26 0.43 4.31

Quarterly Balance Sheets for Astera Labs

This table presents Astera Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 865 916 983 1,122 1,271 1,401 1,659
Total Current Assets		 854 891 946 1,076 1,181 1,290 1,413
Cash & Equivalents		 696 421 126 86 162 140 148
Short-Term Investments		 105 410 761 838 903 994 1,036
Accounts Receivable		 17 22 25 70 24 43 135
Inventories, net		 30 29 24 51 59 52 60
Prepaid Expenses		 6.73 9.45 8.99 30 33 61 34
Plant, Property, & Equipment, net		 7.58 22 35 39 62 72 97
Total Noncurrent Assets		 2.88 2.45 2.34 6.40 29 39 149
Goodwill		 - - - - - - 88
Other Noncurrent Operating Assets		 2.88 2.45 2.34 6.40 29 39 61
Total Liabilities & Shareholders' Equity		 865 916 983 1,122 1,271 1,401 1,659
Total Liabilities		 56 70 93 80 136 129 165
Total Current Liabilities		 46 64 88 77 106 101 125
Accounts Payable		 11 15 19 30 32 26 56
Accrued Expenses		 34 49 69 48 75 75 69
Total Noncurrent Liabilities		 11 6.19 5.41 2.85 29 28 40
Other Noncurrent Operating Liabilities		 11 6.19 5.41 2.85 29 28 40
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 809 845 890 1,042 1,136 1,272 1,494
Total Preferred & Common Equity		 809 845 890 1,042 1,136 1,272 1,494
Total Common Equity		 809 845 890 1,042 1,136 1,272 1,494
Common Stock		 1,027 1,072 1,119 1,217 1,259 1,302 1,404
Retained Earnings		 -218 -226 -234 -177 -126 -35 91
Accumulated Other Comprehensive Income / (Loss)		 -0.06 -0.35 4.43 2.03 2.87 4.10 -0.78

Annual Metrics And Ratios for Astera Labs

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - -
Revenue Growth		 0.00% 44.97% 242.24% 115.13%
EBITDA Growth		 0.00% 51.03% -313.27% 242.00%
EBIT Growth		 0.00% 51.00% -293.48% 249.42%
NOPAT Growth		 0.00% 51.00% -293.48% 314.41%
Net Income Growth		 0.00% 55.00% -217.71% 362.68%
EPS Growth		 0.00% 58.48% 9.86% 290.63%
Operating Cash Flow Growth		 0.00% 64.58% 1,174.83% 133.62%
Free Cash Flow Firm Growth		 0.00% 0.00% -329.86% 140.35%
Invested Capital Growth		 0.00% 0.00% 522.43% 246.19%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 17.91%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 69.14%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 62.67%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 23.20%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 10.19%
EPS Q/Q Growth		 0.00% 0.00% 0.00% -44.55%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 21.07%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 622.60%
Invested Capital Q/Q Growth		 0.00% 0.00% 1,696.44% 27.32%
Profitability Metrics		 - - - -
Gross Margin		 73.47% 68.94% 76.38% 75.69%
EBITDA Margin		 -75.01% -25.34% -30.60% 20.21%
Operating Margin		 -75.36% -25.47% -29.29% 20.34%
EBIT Margin		 -75.36% -25.47% -29.29% 20.34%
Profit (Net Income) Margin		 -73.05% -22.68% -21.05% 25.70%
Tax Burden Percent		 101.33% 114.42% 102.01% 100.45%
Interest Burden Percent		 95.66% 77.80% 70.46% 125.79%
Effective Tax Rate		 0.00% 0.00% 0.00% -0.45%
Return on Invested Capital (ROIC)		 0.00% -509.01% -277.24% 154.63%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -501.49% -276.83% 150.36%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 475.65% 262.37% -135.81%
Return on Equity (ROE)		 0.00% -33.36% -14.87% 18.82%
Cash Return on Invested Capital (CROIC)		 0.00% -709.01% -421.87% 44.28%
Operating Return on Assets (OROA)		 0.00% -15.03% -18.56% 13.41%
Return on Assets (ROA)		 0.00% -13.38% -13.34% 16.95%
Return on Common Equity (ROCE)		 0.00% 20.70% -11.49% 18.82%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 26.87% -8.65% 0.00%
Net Operating Profit after Tax (NOPAT)		 -42 -21 -81 174
NOPAT Margin		 -52.75% -17.83% -20.50% 20.43%
Net Nonoperating Expense Percent (NNEP)		 0.00% -7.51% -0.41% 4.27%
Return On Investment Capital (ROIC_SIMPLE)		 - 21.13% -8.42% 12.77%
Cost of Revenue to Revenue		 26.53% 31.06% 23.62% 24.31%
SG&A Expenses to Revenue		 25.99% 13.75% 23.79% 10.33%
R&D to Revenue		 92.29% 63.39% 50.68% 35.66%
Operating Expenses to Revenue		 148.83% 94.41% 105.67% 55.35%
Earnings before Interest and Taxes (EBIT)		 -60 -29 -116 173
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -60 -29 -121 172
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 21.77 20.61
Price to Tangible Book Value (P/TBV)		 0.00 0.00 21.77 20.61
Price to Revenue (P/Rev)		 8.92 6.16 53.01 32.96
Price to Earnings (P/E)		 0.00 0.00 0.00 128.23
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.78%
Enterprise Value to Invested Capital (EV/IC)		 0.00 100.90 397.91 153.93
Enterprise Value to Revenue (EV/Rev)		 0.00 7.07 50.70 31.57
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 156.16
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 155.17
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 154.48
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 147.02 84.28
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 539.46
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -0.95 -0.95 -0.90
Leverage Ratio		 0.00 1.25 1.11 1.11
Compound Leverage Factor		 0.00 0.97 0.79 1.40
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 162.06% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -62.06% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 11.13 141.30 102.14
Noncontrolling Interest Sharing Ratio		 0.00% 162.06% 22.73% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 5.30 11.71 10.24
Quick Ratio		 0.00 4.49 11.01 9.56
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -29 -124 50
Operating Cash Flow to CapEx		 -926.88% -460.56% 399.11% 850.48%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.59 0.63 0.66
Accounts Receivable Turnover		 0.00 13.89 16.81 13.97
Inventory Turnover		 0.00 1.49 2.78 4.06
Fixed Asset Turnover		 0.00 24.57 19.64 13.35
Accounts Payable Turnover		 0.00 5.68 5.63 5.98
Days Sales Outstanding (DSO)		 0.00 26.27 21.71 26.12
Days Inventory Outstanding (DIO)		 0.00 244.52 131.25 89.98
Days Payable Outstanding (DPO)		 0.00 64.31 64.85 61.00
Cash Conversion Cycle (CCC)		 0.00 206.48 88.12 55.10
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 8.11 50 175
Invested Capital Turnover		 0.00 28.55 13.52 7.57
Increase / (Decrease) in Invested Capital		 0.00 8.11 42 124
Enterprise Value (EV)		 0.00 819 20,094 26,910
Market Capitalization		 713 713 21,008 28,099
Book Value per Share		 $0.00 ($2.63) $6.08 $8.07
Tangible Book Value per Share		 $0.00 ($2.63) $6.08 $8.07
Total Capital		 0.00 157 965 1,364
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 0.00 -149 -914 -1,189
Capital Expenditures (CapEx)		 3.87 2.76 34 38
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 1.42 12 40
Debt-free Net Working Capital (DFNWC)		 0.00 151 926 1,229
Net Working Capital (NWC)		 0.00 151 926 1,229
Net Nonoperating Expense (NNE)		 16 5.61 2.17 -45
Net Nonoperating Obligations (NNO)		 0.00 -149 -914 -1,189
Total Depreciation and Amortization (D&A)		 0.28 0.16 -5.19 -1.10
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 1.22% 3.06% 4.71%
Debt-free Net Working Capital to Revenue		 0.00% 130.17% 233.78% 144.16%
Net Working Capital to Revenue		 0.00% 130.17% 233.78% 144.16%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.64) $1.32
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 131.26M 166.41M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.64) $1.22
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 131.26M 179.55M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 162.15M 170.21M
Normalized Net Operating Profit after Tax (NOPAT)		 -42 -21 -81 121
Normalized NOPAT Margin		 -52.75% -17.83% -20.50% 14.24%
Pre Tax Income Margin		 -72.09% -19.82% -20.64% 25.59%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.54% -6.16% -7.03% 0.00%

Quarterly Metrics And Ratios for Astera Labs

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 170,214,503.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 170,214,503.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.47
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 269.44% 619.03% 206.23% 179.32% 144.33% 149.74% 103.89% 91.77% 93.40%
EBITDA Growth		 0.00% 0.00% -336.85% -41.67% -494.20% -126.24% 111.90% 258.58% 587.12% 2,955.05% 552.02%
EBIT Growth		 0.00% 0.00% -338.35% -38.23% -349.97% -98.40% 113.60% 263.36% 722.82% 46,398.61% 447.92%
NOPAT Growth		 0.00% 0.00% -338.35% -38.23% 2,521.10% -97.25% 128.47% 335.96% 125.34% 11,377.80% 309.09%
Net Income Growth		 0.00% 0.00% -432.80% 62.28% -143.05% 72.52% 134.22% 778.76% 1,299.97% 82.02% 152.40%
EPS Growth		 0.00% 0.00% -261.22% 90.91% 37.50% 200.00% 110.17% 680.00% 1,100.00% -79.67% 144.44%
Operating Cash Flow Growth		 0.00% 0.00% 195.63% 229.84% 19,114.37% 175.73% 187.62% 354.05% 23.09% 139.94% 610.19%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -41.91% 48.38% -292.18% -104.87% -34.54%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 522.43% 1,480.36% 395.39% 4,784.49% 246.19% 164.88%
Revenue Q/Q Growth		 245.51% 36.79% 0.00% 17.76% 47.15% 24.77% 13.00% 20.37% 20.14% 17.35% 13.96%
EBITDA Q/Q Growth		 89.11% 572.87% 0.00% 70.21% 54.34% 79.12% 519.02% 297.44% 40.45% 23.72% -5.59%
EBIT Q/Q Growth		 88.78% 556.25% 0.00% 70.65% 63.46% 101.62% 7,736.81% 252.45% 39.30% 20.85% -7.65%
NOPAT Q/Q Growth		 88.78% 973.08% 0.00% 70.65% 296.60% -99.01% 4,872.39% 143.21% 87.75% -49.45% 77.23%
Net Income Q/Q Growth		 84.38% 558.55% 0.00% 91.89% -0.62% 425.47% 28.75% 60.97% 77.89% -50.63% 78.54%
EPS Q/Q Growth		 85.45% 612.50% 0.00% 97.18% 0.00% 2,560.00% -85.37% 61.11% 72.41% -50.00% 76.00%
Operating Cash Flow Q/Q Growth		 98.55% 4,411.08% 0.00% 716.35% 113.02% -37.48% -73.54% 1,188.71% -42.25% 21.87% -21.69%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 52.19% 198.07% -237.00% -120.93% 82.61% -265.09% -46.05% -45.09%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 92.84% -80.28% 1,696.44% 131.37% -39.55% 94.40% 27.32% 77.03%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 76.11% 77.26% 77.42% 77.88% 77.71% 74.03% 74.89% 75.84% 76.25% 75.57% 76.26%
EBITDA Margin		 -5.14% 17.77% -127.06% -32.14% -9.97% -1.67% 6.19% 20.43% 23.89% 25.19% 20.87%
Operating Margin		 -5.35% 17.86% -127.14% -31.68% -7.87% 0.10% 7.08% 20.72% 24.03% 24.75% 20.05%
EBIT Margin		 -5.35% 17.86% -127.14% -31.68% -7.87% 0.10% 7.08% 20.72% 24.03% 24.75% 20.05%
Profit (Net Income) Margin		 -8.46% 28.36% -142.50% -9.82% -6.71% 17.52% 19.96% 26.69% 39.52% 16.62% 26.04%
Tax Burden Percent		 1,234.78% 133.95% 115.65% 53.58% -376.64% 230.92% 146.52% 101.11% 136.27% 57.00% 109.39%
Interest Burden Percent		 12.80% 118.56% 96.92% 57.84% -22.66% 7,431.94% 192.44% 127.37% 120.68% 117.86% 118.73%
Effective Tax Rate		 0.00% -33.95% 0.00% 0.00% 476.64% -130.92% -46.52% -1.11% -36.27% 43.00% -9.39%
Return on Invested Capital (ROIC)		 0.00% 341.39% 0.00% 0.00% 0.00% 3.19% 81.89% 298.94% 337.96% 106.74% 103.06%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 339.89% 0.00% 0.00% 0.00% -1.40% 80.11% 297.78% 336.41% 106.09% 101.86%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -322.37% 0.00% 0.00% 0.00% 1.32% -74.74% -285.02% -314.60% -95.83% -84.73%
Return on Equity (ROE)		 0.00% 19.02% 0.00% 0.00% 0.00% 4.51% 7.15% 13.92% 23.35% 10.91% 18.33%
Cash Return on Invested Capital (CROIC)		 0.00% -354.50% 0.00% 0.00% 0.00% -421.87% -247.62% -15.49% 9.85% 44.28% 13.83%
Operating Return on Assets (OROA)		 0.00% 10.53% 0.00% 0.00% 0.00% 0.06% 3.49% 11.48% 14.57% 16.31% 14.44%
Return on Assets (ROA)		 0.00% 16.73% 0.00% 0.00% 0.00% 11.10% 9.85% 14.78% 23.97% 10.96% 18.76%
Return on Common Equity (ROCE)		 0.00% -11.80% 0.00% 0.00% 0.00% 3.49% 7.15% 13.92% 23.35% 10.91% 18.33%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.97% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.38 12 -58 -17 34 0.33 17 40 76 38 68
NOPAT Margin		 -3.75% 23.92% -89.00% -22.18% 29.63% 0.24% 10.37% 20.95% 32.75% 14.11% 21.94%
Net Nonoperating Expense Percent (NNEP)		 0.00% 1.50% -8.71% 2.29% -9.27% 4.58% 1.77% 1.16% 1.54% 0.65% 1.20%
Return On Investment Capital (ROIC_SIMPLE)		 - -12.37% - - - 0.03% 1.59% 3.54% 5.94% 2.80% 4.53%
Cost of Revenue to Revenue		 23.89% 22.74% 22.58% 22.12% 22.29% 25.97% 25.11% 24.16% 23.75% 24.43% 23.74%
SG&A Expenses to Revenue		 10.69% 10.60% 37.42% 28.67% 20.22% 17.69% 13.72% 10.66% 9.59% 8.73% 8.36%
R&D to Revenue		 55.85% 38.91% 82.07% 52.17% 44.80% 40.06% 40.49% 34.77% 34.23% 34.66% 40.74%
Operating Expenses to Revenue		 81.46% 59.40% 204.55% 109.57% 85.57% 73.92% 67.82% 55.12% 52.22% 50.82% 56.20%
Earnings before Interest and Taxes (EBIT)		 -1.98 9.02 -83 -24 -8.90 0.14 11 40 55 67 62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.90 8.98 -83 -25 -11 -2.36 9.87 39 55 68 64
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 1.82 11.15 9.23 21.77 9.29 13.13 25.59 20.61 12.49
Price to Tangible Book Value (P/TBV)		 0.00 0.00 1.82 11.15 9.23 21.77 9.29 13.13 25.59 20.61 13.27
Price to Revenue (P/Rev)		 0.00 6.16 0.00 0.00 0.00 53.01 19.73 24.63 45.01 32.96 18.63
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 233.75 148.88 163.66 128.23 69.71
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.43% 0.67% 0.61% 0.78% 1.43%
Enterprise Value to Invested Capital (EV/IC)		 0.00 100.90 90.30 602.55 2,604.21 397.91 74.90 196.05 228.77 153.93 56.45
Enterprise Value to Revenue (EV/Rev)		 0.00 7.07 0.00 0.00 0.00 50.70 17.84 22.87 43.44 31.57 17.45
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 390.19 308.32 156.16 77.04
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 327.29 294.64 155.17 78.01
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 278.07 222.15 154.48 78.65
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 147.02 60.97 55.59 119.10 84.28 45.57
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4,550.24 539.46 592.51
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -0.95 -0.99 -0.98 -1.00 -0.95 -0.93 -0.96 -0.94 -0.90 -0.83
Leverage Ratio		 0.00 1.25 1.07 1.08 1.11 1.11 1.07 1.10 1.10 1.11 1.10
Compound Leverage Factor		 0.00 1.48 1.04 0.63 -0.25 82.83 2.07 1.41 1.33 1.31 1.30
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 162.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -62.06% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 11.77 16.16 81.10 53.38 141.66 73.77 67.39 152.48 101.91 69.46
Noncontrolling Interest Sharing Ratio		 0.00% 162.06% 0.00% 0.00% 0.00% 22.73% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 5.30 18.74 13.91 10.74 11.71 13.92 11.10 12.78 10.24 11.30
Quick Ratio		 0.00 4.49 17.95 13.32 10.36 11.01 12.87 10.24 11.66 9.56 10.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -65 -31 31 -42 -93 -16 -59 -86 -125
Operating Cash Flow to CapEx		 -45.38% 1,424.23% 106.66% 0.00% 380.36% 257.01% 231.42% 6,691.35% 635.90% 509.74% 983.36%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.59 0.00 0.00 0.00 0.63 0.49 0.55 0.61 0.66 0.72
Accounts Receivable Turnover		 0.00 13.89 0.00 0.00 0.00 16.81 11.34 26.02 21.18 13.97 9.79
Inventory Turnover		 0.00 1.49 0.00 0.00 0.00 2.78 2.95 3.40 4.67 4.06 4.32
Fixed Asset Turnover		 0.00 24.57 0.00 0.00 0.00 19.64 20.85 14.44 13.44 13.35 14.66
Accounts Payable Turnover		 0.00 5.68 0.00 0.00 0.00 5.63 5.80 6.42 8.02 5.98 5.64
Days Sales Outstanding (DSO)		 0.00 26.27 0.00 0.00 0.00 21.71 32.20 14.03 17.24 26.12 37.28
Days Inventory Outstanding (DIO)		 0.00 244.52 0.00 0.00 0.00 131.25 123.77 107.31 78.09 89.98 84.41
Days Payable Outstanding (DPO)		 0.00 64.31 0.00 0.00 0.00 64.85 62.91 56.83 45.53 61.00 64.76
Cash Conversion Cycle (CCC)		 0.00 206.48 0.00 0.00 0.00 88.12 93.06 64.51 49.79 55.10 56.93
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 8.11 7.39 14 2.81 50 117 71 137 175 309
Invested Capital Turnover		 0.00 14.27 0.00 0.00 0.00 13.52 7.90 14.27 10.32 7.57 4.70
Increase / (Decrease) in Invested Capital		 0.00 0.00 7.39 14 2.81 42 109 56 134 124 193
Enterprise Value (EV)		 0.00 819 668 8,590 7,320 20,094 8,751 13,847 31,411 26,910 17,471
Market Capitalization		 713 713 1,469 9,421 8,207 21,008 9,676 14,912 32,546 28,099 18,656
Book Value per Share		 $0.00 ($2.63) $15.40 $5.43 $5.68 $6.08 $6.42 $6.89 $7.65 $8.07 $8.78
Tangible Book Value per Share		 $0.00 ($2.63) $15.40 $5.43 $5.68 $6.08 $6.42 $6.89 $7.65 $8.07 $8.26
Total Capital		 0.00 157 809 845 890 965 1,042 1,136 1,272 1,364 1,494
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 -149 -801 -831 -887 -914 -925 -1,065 -1,134 -1,189 -1,184
Capital Expenditures (CapEx)		 0.74 1.01 3.42 -1.32 17 15 4.54 2.02 12 19 7.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 1.42 7.46 -3.82 -29 12 74 9.28 55 40 103
Debt-free Net Working Capital (DFNWC)		 0.00 151 809 827 858 926 999 1,074 1,189 1,229 1,288
Net Working Capital (NWC)		 0.00 151 809 827 858 926 999 1,074 1,189 1,229 1,288
Net Nonoperating Expense (NNE)		 1.74 -2.24 35 -9.50 41 -24 -15 -11 -16 -6.82 -13
Net Nonoperating Obligations (NNO)		 0.00 -149 -801 -831 -887 -914 -925 -1,065 -1,134 -1,189 -1,184
Total Depreciation and Amortization (D&A)		 0.08 -0.05 0.05 -0.35 -2.38 -2.50 -1.42 -0.56 -0.32 1.19 2.51
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 1.22% 0.00% 0.00% 0.00% 3.06% 15.05% 1.53% 7.58% 4.71% 10.33%
Debt-free Net Working Capital to Revenue		 0.00% 130.17% 0.00% 0.00% 0.00% 233.78% 203.59% 177.42% 164.47% 144.16% 128.60%
Net Working Capital to Revenue		 0.00% 130.17% 0.00% 0.00% 0.00% 233.78% 203.59% 177.42% 164.47% 144.16% 128.60%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.41 ($1.77) ($0.05) ($0.05) $1.23 $0.19 $0.31 $0.54 $0.28 $0.47
Adjusted Weighted Average Basic Shares Outstanding		 0.00 37.13M 52.53M 155.20M 156.83M 131.26M 163.19M 165.43M 167.44M 166.41M 170.73M
Adjusted Diluted Earnings per Share		 $0.00 $0.41 ($1.77) ($0.05) ($0.05) $1.23 $0.18 $0.29 $0.50 $0.25 $0.44
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 37.13M 52.53M 155.20M 156.83M 131.26M 178.12M 178.10M 180.63M 179.55M 181.16M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 155.70M 156.66M 158.61M 162.15M 164.92M 166.22M 168.90M 170.21M 171.41M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.38 6.31 -58 -17 -6.23 0.10 7.90 28 39 38 43
Normalized NOPAT Margin		 -3.75% 12.50% -89.00% -22.18% -5.51% 0.07% 4.95% 14.51% 16.82% 14.11% 14.04%
Pre Tax Income Margin		 -0.69% 21.17% -123.22% -18.33% 1.78% 7.58% 13.62% 26.40% 29.00% 29.16% 23.81%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -6.16% 0.00% 0.00% 0.00% -7.03% 9.93% 1.06% 0.54% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the top takeaways for Astera Labs (ALAB) based on the last four years of quarterly statements, with a focus on the most recent four quarters. The items are ordered with positives first, then neutral, then negatives.

  • Revenue growth acceleration in 2025: 2025 Q4 revenue reached $270.6M, up from $159.4M in 2025 Q1 and $230.6M in 2025 Q3, signaling strong top‑line expansion.
  • Gross margin remains healthy and relatively stable: 2025 Q4 gross margin ≈ 75.8% (gross profit $204.5M on $270.6M revenue), with similar levels in 2025 Q3 and mid‑70s in 2024.
  • Robust quarterly operating cash flow: Net cash from continuing operating activities was about $95.3M in 2025 Q4 and $78.2M in 2025 Q3, indicating solid cash generation from core operations.
  • Strong liquidity position: As of 2025, the company held substantial liquid assets (large short‑term investments, plus cash on hand), supporting near‑term liquidity and flexibility.
  • Rising equity base and solid balance sheet: Total equity increased through 2025, reaching roughly $1.27B by 2025 Q3, reflecting retained earnings growth and a strengthening capital position.
  • Ongoing but sizable R&D investment: Research & Development expense remains a major cost driver (e.g., $93.8M in 2025 Q4; $78.9M in 2025 Q3), underscoring continued product development efforts.
  • Earnings per share exhibit volatility tied to share count: Weighted average shares rose through 2025 (approx. 166–181M), with diluted EPS of $0.25 in 2025 Q4 vs $0.50 in 2025 Q3, suggesting dilution effects and quarterly earnings volatility.
  • Capex remains modest but rising in 2025: Capital expenditures stepped up (e.g., $18.7M in 2025 Q4; $12.3M in 2025 Q3), signaling ongoing investment in facilities or equipment.
  • Significant investing activity weighing on cash flow: Net cash used in investing activities was substantial in 2025 (Q4: −$72.8M; Q3: −$101.0M; Q2: −$63.7M; Q1: −$3.97M), limiting near‑term free cash flow.
  • Notable quarterly earnings variability warranting scrutiny: A large quarterly net income spike in 2025 Q3 (net income ≈ $91.1M) followed by lower 2025 Q4 profitability (~$45.0M) points to earnings quality volatility and potential one‑time effects.
05/26/26 06:18 AM ETAI Generated. May Contain Errors.

Astera Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Astera Labs' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Astera Labs' net income appears to be on an upward trend, with a most recent value of $219.13 million in 2025, falling from -$58.35 million in 2022. The previous period was -$83.42 million in 2024. See where experts think Astera Labs is headed by visiting Astera Labs' forecast page.

Astera Labs' total operating income in 2025 was $173.42 million, based on the following breakdown:
  • Total Gross Profit: $645.26 million
  • Total Operating Expenses: $471.84 million

Over the last 3 years, Astera Labs' total revenue changed from $79.87 million in 2022 to $852.53 million in 2025, a change of 967.4%.

Astera Labs' total liabilities were at $168.19 million at the end of 2025, a 87.5% increase from 2024, and a 332.7% increase since 2023.

In the past 2 years, Astera Labs' cash and equivalents has ranged from $45.10 million in 2023 to $167.61 million in 2025, and is currently $167.61 million as of their latest financial filing in 2025.

Over the last 3 years, Astera Labs' book value per share changed from 0.00 in 2022 to 8.07 in 2025, a change of 807.3%.


Related Companies

Financial statements for NASDAQ:ALAB last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel